Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: An Italian perspective

European Heart Journal

Volumn 34, Issue 7, 2013, Pages 520-528

  Rapezzi, Claudio ^a   Quarta, Candida Cristina ^a   Obici, Laura ^b   Perfetto, Federico ^c   Longhi, Simone ^a   Salvi, Fabrizio ^d   Biagini, Elena ^a   Lorenzini, Massimiliano ^a   Grigioni, Francesco ^a   Leone, Ornella ^a   Cappelli, Francesco ^c   Palladini, Giovanni ^b   Rimessi, Paola ^e   Ferlini, Alessandra ^e   Arpesella, Giorgio ^a   Pinna, Antonio Daniele ^a   Merlini, Giampaolo ^b   Perlini, Stefano ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d BELLARIA HOSPITAL   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cardiac phenotype; Genotypic phenotypic correlations; Hereditary transthyretin related amyloidosis; Hypertrophic cardiomyopathy; Senile systemic amyloidosis; Symmetric left ventricular hypertrophy

Indexed keywords

PREALBUMIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILIAL AMYLOIDOSIS; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HEART AMYLOIDOSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AMYLOID NEUROPATHIES, FAMILIAL; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENOTYPE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 84874259441     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs123     Document Type: Article

References (41)

1. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062.
2. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58: 1001-1007.
3. Suhr OB, Svendsen IH, Andersson R, Danielsson A, Holmgren G, Ranløv PJ. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 2003;254:225-235.
4. Bittencourt PL, Couto CA, Clemente C, Farias AQ, Palácios SA, Mies S, Goldberg AC. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur J Neurol 2005;12:289-293.
5. Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late-and early-onset cases in Portugal. Muscle Nerve 2007;35:116-118.
6. Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, Ciliberti P, Biagini E, Salvi F, Branzi A. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 2010;7:398-408.
7. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-473.
8. Sattianayagam PT, Hahn AF, Whelan CJ, Gibbs SD, Pinney JH, Rowczenio D, Pflugfelder PW, Fox Z, Lachmann HJ, Wechalekar AD, Hawkins PN, Gillmore JD. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J 2012; 33:1120-1127.
9. Ranløv I, Alves IL, Ranløv PJ, Husby G, Costa PP, Saraiva MJ. A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med 1992;93:3-8.
10. Almeida MR, Hesse A, Steinmetz A, Maisch B, Altland K, Linke RP, Gawinowicz MA, Saraiva MJ. Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol 1991;86:567-571.
11. Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52: 347-361.
12. Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol 2010;55:1769-1779.
13. Ferlini A, Fini S, Salvi F, Patrosso MC, Vezzoni P, Forabosco A. Molecular strategies in genetic diagnosis of transthyretin-related hereditary amyloidosis. FASEB J 1992;6:2864-2866.
14. Westermark P, Sletten K, Johansson B, Cornwell GG. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87:843-845.
15. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005;79: 319-328.
16. Suhr OB, Lindqvist P, Olofsson B-E, Waldenstroom A, Backman C. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid 2006;13:154-159.
17. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, Coccolo F, Cooke RM, Bacchi-Reggiani L, Sangiorgi D, Ferlini A, Cavo M, Zamagni E, Fonte ML, Palladini G, Salinaro F, Musca F, Obici L, Branzi A, Perlini S. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212.
18. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411-423.
19. Coutinho P, Martins da Silva A, Lopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid neuropathy. In Glenner GG, Costa PP, Freitas AF, eds. Amyloid and Amyloidosis. Amsterdam: Excerpta Medica; 1980. p88-98.
20. Surawicz B, Knilans TK, eds. Chou's Electrocardiography in Clinical Practice: Adult and Pediatric. 5th ed. Philadelphia: W. B. Saunders; 2001.
21. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Guidelines update for the clinical application of echocardiography. Circulation 2003;108:1146-1162.
22. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
23. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-193.
24. Plante-Bordeneuve V, Lalu T, Misrahi M, Reilly MM, Adams D, Lacroix C, Said G. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 1998;51:708-714.
25. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999;282:153-158.
26. Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J 2009;158:607-614.
27. Staunton H, Davis MB, Guiloff RJ, Nakazato M, Miyazato N, Harding AE. Irish (Donegal) amyloidosis is associated with the transthyretinALA60 (Appalachian) variant. Brain 1991;114:2675-2679.
28. Almeida MR, Ferlini A, Forabosco A, Gawinowicz M, Costa PP, Salvi F, Plasmati R, Tassinari CA, Altland K, Saraiva MJ. Two transthyretin variants (TTR Ala-49 and TTR Gln89) in two Sicilian kindreds with hereditary amyloidosis. Hum Mutat 1992;1:211-215.
29. Solaro C, Schenone A, Di Sapio A, Pradotto L, Mancardi GL, Primavera A, Mauro A. An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. Neuromusc Disord 2000;10:52-55.
30. Patrosso MC, Vezzoni P, Salvi F, Gobbi P, Winter P, Altland K, Ferlini A. Two new mutations in the transthyretin gene leading to polyneuropathy and cardiomyopathy in two unrelated Italian families. Neuromuscular Disord (Suppl) 1996;6:S23.
31. Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005;121:73-85.
32. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253-261.
33. Buxbaum JN, Tagoe C, Gallo G,Walker JR, Kurian S, Salomon DR. Why are some amyloidoses systemic? Does hepatic 'chaperoning at a distance' prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis? FASEB J 2012;26:2283-2293.
34. Rapezzi C, Riva L, Quarta CC, Perugini E, Salvi F, Longhi S, Ciliberti P, Pastorelli F, Biagini E, Leone O, Cooke RM, Bacchi-Reggiani L, Ferlini A, Cavo M, Merlini G, Perlini S, Pasquali S, Branzi A. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid 2008;15:40-68.
35. Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail 2011;4: 121-128.
36. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, Hare JM, Baughman KL, Kasper EK. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-415.
37. Herlenius G, Wilczek HE, Larsson M, Ericzon BG, Familial Amyloidotic Polyneuropathy World Transplant Registry. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004;77:64-71.
38. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80.
39. Hamour IM, Lachmann HJ, Goodman HJ, Petrou M, Burke MM, Hawkins PN, Banner NR. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. Am J Transplant 2008;8:1056-1059.
40. Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13: 236-249.
41. Ratner M. Spotlight focuses on protein-misfolding therapies. Nat Biotechnol 2009; 27:874.